パーキンソン病の疫学
Yoav Ben-Shlomo1, Sirwan Darweesh2, Jorge Llibre-Guerra3
1Population Health Sciences, Bristol Medical School, University of Bristol, Bristol, UK.
Lancet (London, England)
|January 20, 2024
まとめ
パーキンソン病の流行病学は,環境要因と高齢化による世界的な変動と増加傾向を示しています. これらの傾向を理解することは 効果的な予防戦略の開発に不可欠です
科学分野:
- 流行病学について
- 神経変性疾患
- 公衆衛生
背景:
- パーキンソン病 (PD) の流行病学は,時間,地域,民族,年齢,性別によって大きく変化しています.
- PDの国際的流行は 人口の変化を超えて増加しており,他の原因による死亡率の減少が原因である可能性があります.
- PDは高齢者や男性に多く見られ 神経毒素などの環境関連が疑われるが,特に女性や低所得国における発症傾向はさらなる調査を必要としている.
研究 の 目的:
- パーキンソン病の流行病学的変化と傾向を分析する.
- パーキンソン病のリスクに寄与する環境的および遺伝的要因を探求する.
- 神経退行性疾患の重要性を強調し,複数の予防戦略の必要性を強調する.
主な方法:
- パーキンソン病の流行と発生に関する疫学データのレビュー
- 病気の発生における人口,地域,民族の変動の分析
- 農薬とライフスタイルの選択を含む環境リスクと保護要因の検討
主要な成果:
- パーキンソン病の罹患率は 世界的に増加しています
- 農薬への曝露などの環境要因は 危険因子として挙げられ 身体活動や喫煙は 保護的かもしれない.
- リスクにおける民族的差異は,医療へのアクセスによって影響を受けることがあります.
結論:
- パーキンソン病は多因性で 遺伝子と環境の相互作用が複雑です
- 効果的な予防には,一次,二次,三次的な予防に取り組む統合された戦略が必要です.
- パーキンソン病の国際的理解と制御を進めるには 国際的な研究協力が不可欠です
さらに関連する動画
06:07Author Spotlight: Establishing a New Fluorescence-Based Protocol for In Vivo Mitochondrial Morphology Analysis in Parkinson's Disease
Published on: June 23, 2023
1.6K
14:45Analyzing the Parkinson's Disease Mouse Model Induced by Adeno-associated Viral Vectors Encoding Human α-Synuclein
Published on: July 29, 2022
6.0K
関連する概念動画
01:15Parkinson's Disease: Overview
551
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
551
01:24Parkinson's Disease: Treatment
272
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
272
01:37Neural Regulation
39.4K
Digestion begins with a cephalic phase that prepares the digestive system to receive food. When our brain processes visual or olfactory information about food, it triggers impulses in the cranial nerves innervating the salivary glands and stomach to prepare for food.
39.4K
01:22Lysosomal Hydrolases
3.8K
Lysosomes are the site for the degradation of macromolecules and biological polymers released during membrane trafficking events such as secretory, endocytic, autophagic, and phagocytic pathways. The membrane-enclosed area of the lysosome, called the lumen, contains hydrolytic enzymes active in an acidic environment. These acid hydrolases are functional at a pH between 4.5 and 5 and are involved in cellular processes such as cell signaling, energy metabolism, restoration of the plasma membrane,...
3.8K
01:27Psychosis: Pathophysiology of Schizophrenia and Other Psychotic Disorders
657
Schizophrenia is a neurodevelopmental disorder whose origins are rooted in complex genetic components. Despite our burgeoning understanding, the pathophysiology of this disorder remains incompletely deciphered.
Researchers have identified genetic factors that increase susceptibility to schizophrenia, underscoring the intricate interplay between genetics and environment in disease development. At the core of schizophrenia's pathophysiology is excessive dopaminergic neurotransmission within...
Researchers have identified genetic factors that increase susceptibility to schizophrenia, underscoring the intricate interplay between genetics and environment in disease development. At the core of schizophrenia's pathophysiology is excessive dopaminergic neurotransmission within...
657
01:26Alzheimer's Disease: Overview
490
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
490